SOAT1 and myeloid sarcoma: This study emphasized the function of the JAK/STAT signaling pathway in modulating monocyte migration and suggests that laquinimod’s effects on this pathway offer a protective mechanism in the EAE model, which could provide therapeutic strategies for MS treatment [23].